Cronos Group Inc traded at 3.60 this Thursday June 30th, decreasing 0.09 or 2.44 percent since the previous trading session. Looking back, over the last four weeks, Cronos Group Inc lost 5.51 percent. Over the last 12 months, its price fell by 65.01 percent. Looking ahead, we forecast Cronos Group Inc to be priced at 3.94 by the end of this quarter and at 3.68 in one year, according to Trading Economics global macro models projections and analysts expectations.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Peers Price Day Year
Aurora Cannabis Inc 1.70 -0.06 -3.41% -83.98%
British American Tobacco 3,529.00 9.50 0.27% 25.10%
Brown Forman Class A 68.24 0.60 0.89% -8.45%
Imperial Brands PLC 1,841.50 5.50 0.30% 17.22%
Coca-Cola 63.49 0.58 0.92% 17.18%
Monster Beverage 93.13 0.43 0.46% 2.49%
Altria 41.61 -0.16 -0.38% -12.46%
Philip Morris International 98.16 -0.58 -0.59% -2.13%
Boston Beer 313.20 10.23 3.38% -67.16%
Constellation Brands 230.65 -2.42 -1.04% -0.33%
Molson Coors Brewing 54.64 0.13 0.24% 1.54%
Canopy Growth Corp 3.66 -0.83 -18.49% -87.25%

Indexes Price Day Year
CATSX 18861 -217.28 -1.14% -6.75%

Cronos Group Inc
Cronos Group Inc is a cannabinoid company. The Company is focused on cannabis research, technology and product development. The Company’s portfolio includes PEACE NATURALS, COVE, Spinach, Lord Jones and PEACE+. PEACE NATURALS a global wellness platform. The COVE and Spinach are adult-use brands. The Lord Jones and PEACE+ are hemp-derived cannabidiol (CBD) brands. The Company’s segments include United States and Rest of World. The United States segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s subsidiaries include Cronos Israel G.S. Cultivations Ltd, Cronos Israel G.S. Manufacturing Ltd, Cronos Israel G.S. Store Ltd and Cronos Israel G.S. Pharmacies Ltd.